1 Department of Health Policy and Management, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA lshi1@tulane.edu.
2 Pharmacoeconomics Committee, Association of Health Economics of Beijing, Beijing.
3 School of Public Health, Peking University, Beijing.
4 Department of Pharmacy, Peking Union Medical College Hospital, Beijing.
A requirement to assess actual use of reimbursed medicines would enable transparent, documented, evidence based decisions on disinvestment, say Lizheng Shiand colleagues